NCT00530920 - Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Conditions

HIV Infections

Interventions

DRUG

tipranavir

DRUG

ritonavir

Trial Locations (12)

1182.107.49002 Boehringer Ingelheim Investigational Site, Berlin

1182.107.49004 Boehringer Ingelheim Investigational Site, Berlin

1182.107.49003 Boehringer Ingelheim Investigational Site, Frankfurt am Main

1182.107.49001 Boehringer Ingelheim Investigational Site, München

1182.107.39001 Boehringer Ingelheim Investigational Site, Antella (fi)

1182.107.39009 Boehringer Ingelheim Investigational Site, Bari

1182.107.39007 Boehringer Ingelheim Investigational Site, Ferrara

1182.107.39011 Boehringer Ingelheim Investigational Site, Palermo

1182.107.34001 Boehringer Ingelheim Investigational Site, Barcelona

1182.107.34002 Boehringer Ingelheim Investigational Site, Barcelona

1182.107.34003 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat

1182.107.34004 Boehringer Ingelheim Investigational Site, Madrid